CAS RN: 252003-65-9
CP-547632
Product Availability
Choose a grade to view its available package options.
7 package records5 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20251006 |
100mg |
Out of stock |
| Inquiry |
| Batchno.20250908 |
10mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250715 |
1mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250930 |
250mg |
Out of stock |
| Inquiry |
| Batchno.20251018 |
25mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250517 |
50mg |
In stock |
Shanghai | Inquiry |
| Batchno.20260209 |
5mg |
In stock |
Shanghai | Inquiry |
-
Product code:
starshine_CAS252003-65-9
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
252003-65-9 / 3-[(4-bromo-2,6-difluorophenyl)methoxy]-5-(4-pyrrolidin-1-ylbutylcarbamoylamino)-1,2-thiazole-4-carboxamide
Standard CAS: 252003-65-9
Multi CAS: No
Basic Information
CAS
252003-65-9
Multi CAS
No
Molecular Formula
C20H24BrF2N5O3S
Molecular Weight
532.400000
Exact Mass
531.075130
SMILES
C1CCN(C1)CCCCNC(=O)NC2=C(C(=NS2)OCC3=C(C=C(C=C3F)Br)F)C(=O)N
InChI
InChI=1S/C20H24BrF2N5O3S/c21-12-9-14(22)13(15(23)10-12)11-31-18-16(17(24)29)19(32-27-18)26-20(30)25-5-1-2-6-28-7-3-4-8-28/h9-10H,1-8,11H2,(H2,24,29)(H2,25,26,30)
InChIKey
HXHAJRMTJXHJJZ-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
32
Aromatic heavy atom count
11
Fraction Csp3
0.45
Rotatable bonds
10
H-bond acceptors
6
H-bond donors
3
Molar refractivity
120.95
TPSA
109.58
LogP / Solubility
WLOGP
3.86
MLOGP
3.44
XLogP3
3.7
Consensus LogP
3.67
Log S (ESOL)
-5.17
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.71
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.52
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-3.23
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2.5